Mu and delta receptors mediate morphine effects on phagocytosis by murine peritoneal macrophages

Nilka Tomassini1, Fernando L Renaud, Sabita Roy

  • 1Biology Department, University of Puerto Rico, POB 23360 Río Piedras Campus, San Juan 00931-3360, Puerto Rico.

Insights

Mu and delta(2)-opioid receptors, not kappa, inhibit macrophage phagocytosis. These opioid receptors modulate each other

Area of Science:

  • Immunology
  • Neuroscience
  • Pharmacology

Background:

  • Opioid receptors are known to modulate immune cell functions.
  • Phagocytosis is a critical immune process involving the engulfment of pathogens by immune cells.

Purpose of the Study:

  • To investigate the specific roles of mu-, delta-, and kappa-opioid receptors in the inhibition of phagocytosis in murine macrophages.
  • To explore the potential interactions and cooperative mechanisms between mu- and delta-opioid receptors in regulating phagocytosis.

Main Methods:

  • Utilized selective opioid agonists and antagonists to study their effects on phagocytosis in elicited murine macrophages.
  • Employed mu-opioid receptor knockout (MORKO) mice to assess the impact of receptor absence on agonist efficacy.
  • Analyzed dose-response curves to determine receptor involvement and cooperativity.

Main Results:

  • Mu- and delta(2)-opioid receptors, but not kappa receptors, were found to inhibit phagocytosis.
  • All tested mu and delta(2) agonists demonstrated similar maximal effects, with dose-response curves indicating positive cooperativity.
  • Mu- and delta-opioid antagonists effectively blocked the effects of both mu- and delta-opioid agonists.
  • In MORKO mice, a delta-opioid agonist showed reduced potency and maximal effect, suggesting mu-delta receptor interaction.

Conclusions:

  • Mu- and delta-opioid receptors play significant roles in modulating macrophage phagocytosis.
  • Evidence suggests a cooperative mechanism between mu- and delta-opioid receptors, where they influence each other's activity.
  • Further research is needed to elucidate the precise molecular mechanisms underlying this opioid receptor cross-talk in immune cells.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.